5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.59▼ | 5.70▼ | 5.70▼ | 5.90▼ | 6.74▼ |
MA10 | 5.57▼ | 5.56▼ | 5.56▼ | 6.39▼ | 3.80▲ |
MA20 | 5.89▼ | 5.97▼ | 6.13▼ | 7.21▼ | 2.44▲ |
MA50 | 6.78▼ | 6.93▼ | 7.22▼ | 3.56▲ | 4.02▲ |
MA100 | 6.40▼ | 5.08▲ | 4.36▲ | 2.34▲ | 826.28▼ |
MA200 | 3.63▲ | 2.97▲ | 2.64▲ | 3.59▲ | 10,898.99▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.029▲ | 0.022▲ | -0.047▼ | -0.438▼ | 5.888▲ |
RSI | 36.664▼ | 37.779▼ | 37.579▼ | 48.581▼ | 36.546▼ |
STOCH | 51.693 | 58.684 | 39.464 | 20.070 | 58.375 |
WILL %R | -74.866 | -74.866 | -88.941▼ | -85.882▼ | -46.983 |
CCI | -45.293 | -49.118 | -68.008 | -124.802▼ | 66.909 |
Monday, August 18, 2025 07:27 PM
Register for the three-day event here FRENCHTOWN, NJ / ACCESS Newswire / August 15, 2025 / JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today announced ...
|
Monday, August 18, 2025 07:27 PM
Register for the three-day event here FRENCHTOWN, NJ / ACCESS Newswire / August 15, 2025 / JTC Team (“JTC”), a fully integrated corporate communications and investor relations firm, today announced ...
|
Friday, August 15, 2025 12:02 PM
CNS Pharmaceuticals (NASDAQ: CNSP) , a biopharmaceutical company developing treatments for cancers in the brain and central nervous system, reported ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/08/25 | 6.19 | 6.19 | 5.31 | 5.41 | 26,605 |
18/08/25 | 5.31 | 6.25 | 5.1101 | 6.19 | 82,100 |
15/08/25 | 6.31 | 6.3292 | 4.93 | 5.09 | 77,150 |
14/08/25 | 7.15 | 7.745 | 5.728 | 6.03 | 84,307 |
13/08/25 | 6.59 | 7.55 | 6.32 | 6.79 | 38,708 |
12/08/25 | 6.74 | 6.79 | 6.2801 | 6.57 | 31,728 |
11/08/25 | 6.77 | 6.93 | 6.44 | 6.6301 | 18,488 |
08/08/25 | 7.00 | 7.0399 | 6.656 | 6.70 | 13,096 |
07/08/25 | 7.53 | 7.53 | 6.83 | 6.99 | 27,838 |
06/08/25 | 7.63 | 7.6963 | 7.24 | 7.45 | 15,911 |
|
|
||||
|
|
||||
|
|